UK markets closed

Vericel Corporation (VCEL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
52.93+1.35 (+2.62%)
As of 03:13PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 2.51B
Enterprise value 2.49B
Trailing P/E 5.16k
Forward P/E 285.71
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.86
Price/book (mrq)10.72
Enterprise value/revenue 11.98
Enterprise value/EBITDA 370.02

Trading information

Stock price history

Beta (5Y monthly) 1.70
52-week change 337.91%
S&P500 52-week change 321.83%
52-week high 353.44
52-week low 330.18
50-day moving average 347.07
200-day moving average 342.48

Share statistics

Avg vol (3-month) 3371.36k
Avg vol (10-day) 3323.1k
Shares outstanding 548.6M
Implied shares outstanding 648.6M
Float 848.15M
% held by insiders 10.93%
% held by institutions 1107.17%
Shares short (28 Jun 2024) 43.48M
Short ratio (28 Jun 2024) 48.08
Short % of float (28 Jun 2024) 411.46%
Short % of shares outstanding (28 Jun 2024) 47.16%
Shares short (prior month 31 May 2024) 44.83M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 316 Oct 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.22%
Operating margin (ttm)-10.66%

Management effectiveness

Return on assets (ttm)-0.75%
Return on equity (ttm)0.21%

Income statement

Revenue (ttm)207.78M
Revenue per share (ttm)4.35
Quarterly revenue growth (yoy)25.00%
Gross profit (ttm)N/A
EBITDA 1.1M
Net income avi to common (ttm)451k
Diluted EPS (ttm)0.01
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)110.65M
Total cash per share (mrq)2.28
Total debt (mrq)92.15M
Total debt/equity (mrq)39.40%
Current ratio (mrq)5.20
Book value per share (mrq)4.82

Cash flow statement

Operating cash flow (ttm)34.65M
Levered free cash flow (ttm)-4.63M